Clinical Trial Update: Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of carbetocin nasal spray for hyperphagia in Prader-Willi syndrome is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Carbetocin nasal spray (carbetocin)

Snippet

Sponsor: ACADIA Pharmaceuticals Inc. | Conditions: Hyperphagia in Prader-Willi Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING